How effective is Novavax’s vaccine?
Moreover, the Novavax vaccine was shown to be 100% effective in stopping moderate and severe COVID-19.
Does it work against COVID-19 variants?
The two-dose vaccine is 93% effective against some COVID-19 variants, according to Novavax, specifically those of concern and interest. It did not mention specific variants.
When will the Novavax vaccine be available?
Novavax said it plans to submit its vaccine for approval from the Food and Drug Administration in the third quarter of 2021.
Is this good news?
- “These data show consistent, high levels of efficacy and reaffirm the ability of the vaccine to prevent COVID-19 amid ongoing genetic evolution of the virus. Our vaccine will be a critical part of the solution to COVID-19 and we are grateful to the study participants and trial staff who made this study possible, as well as our supporters, including the U.S. Government.”